Mint Solutions, an Amsterdam- and Island-based company developing and marketing the medication safety system MedEye, has raised €5 million in a Series B funding round led by BOM Capital and existing shareholders LSP and Seventure Partners. Other shareholders, including NSA Ventures and a number of private Icelandic investors, also participated in the financing round.
The fresh capital will be used to support the rollout of Mint’s proprietary MedEye system, which aims to stop and prevent medication errors and improve efficiency in hospitals and care institutions. Through a combination of innovative hardware and software and seamless integration with hospital information systems, MedEye enables nurses to automatically verify medication at the bedside, thus ensuring that patients get the right medication, in the right dose and at the right time. Following successful deployment at several Dutch hospitals, Mint is preparing to expand into adjacent market segments and additional countries.
Gauti Reynisson, the CEO of Mint Solutions stated: “This investment comes at a crucial time for our MedEye product. We are experiencing strong demand from Dutch hospitals and we see ample growth opportunity in other care segments, including long-term care, as well as international markets. The new funding allows us to roll out MedEye and increase medication safety in even more hospitals and care institutions both in and outside the Netherlands.”
“The MedEye system has proven to significantly reduce medication errors, providing a great benefit for both hospitals and individual patients,” commented Miriam Dragstra, Director of BOM Capital. “We are pleased to be joining Mint Solutions now, as the company prepares to relocate its headquarters to the Brabant region to participate in the regional ecosystem around MedTech and e-health solutions.”
Mint Solutions is a Dutch-Icelandic medical startup that was established to improve medication safety in hospitals and care institutions. The company was founded in 2010. Check out the video below to learn more about their flagship product MedEye: